Eurogentec

Eurogentec is a Belgian biotech CDMO manufacturing oligonucleotides, reagents, and diagnostic solutions for research, diagnostics, and therapeutics since 1985.

1985 Founded2 People on the graph8 News mentions

Overview

Eurogentec, registered as Kaneka Eurogentec S.A., is a biotechnology company and contract development and manufacturing organisation based in the Liege Science Park in Seraing. It was founded in 1985 as a spin-off of the University of Liege by professors Joseph Martial and Andre Renard, together with industrialists Jean-Claude Lahaut and Hubert Vandecapelle, and its first work centred on a genetically engineered vaccine to improve fish breeding. It began synthesising oligonucleotides for research laboratories in 1987 and moved into contract manufacturing for the biopharmaceutical sector in 1996, working with SmithKline Beecham. The catalogue and services span oligonucleotides, PCR and qPCR reagents and kits, peptides, proteins and polyclonal, monoclonal and VHH antibodies. GMP services cover plasmid DNA, produced since 2004 at gram to kilogram scale, mRNA in batches of 0.5 to 50 grams, recombinant proteins and antibody fragments in E. coli and P. pastoris, therapeutic oligonucleotides and peptides. Eurogentec has more than 10,000 square metres of production area across four manufacturing sites, two in Belgium, one in the United Kingdom and one in the United States, and reports 492 employees worldwide. It acquired Oswel Research Products in 1999, Wita Proteomics in 2002 and AnaSpec in 2009. Kaneka Corporation took a majority stake in 2010. Lieven Janssens is president.

Stated facts & numbers

  • Founded: 1985
  • Legal name: Kaneka Eurogentec S.A.
  • Headquarters: Seraing (Liege Science Park), Belgium
  • Founders: Joseph Martial, Andre Renard, Jean-Claude Lahaut, Hubert Vandecapelle
  • President: Lieven Janssens
  • Employees: 492 worldwide
  • Parent company: Kaneka Corporation, majority stake since 2010
  • Sites: Four manufacturing sites: two in Belgium, one in the United Kingdom, one in the United States
  • Production area: Over 10,000 m2
  • Business units: Research products, diagnostic services, therapeutic manufacturing
  • Catalogue: More than 11,000 genomics and proteomics items
  • GMP modalities: Plasmid DNA, mRNA, recombinant proteins and antibody fragments, therapeutic oligonucleotides, peptides
  • Acquisitions: Oswel Research Products (1999), Wita Proteomics (2002), AnaSpec (2009)
  • US operation: AnaSpec Inc. and Eurogentec US, Fremont, California

Key people

In the news

Alumni 4 went on to found or lead

The full Eurogentec mafia →

Something wrong or missing? Send an update. Fixed within 24 hours.